<DOC>
	<DOCNO>NCT01018251</DOCNO>
	<brief_summary>This study investigate sensitivity specificity FLT-PET/CT primary breast cancer detection use FLT-PET monitoring well breast tumor respond treatment . We compare technique image modality well tissue collection ( biopsy ) . We recruit woman newly diagnose invasive breast cancer , able tolerate undergoing PET/CT ( possibly two scan ) scan ,</brief_summary>
	<brief_title>Positron Emission Tomography Monitoring Treatment Response Women With Newly Diagnosed Breast Cancer</brief_title>
	<detailed_description>Our overall goal use clinical trial platform validate fibroblast activation protein ( FAP ) biomarker tumor microenvironment explore dynamic interaction proliferate tumor cell tumor microenvironment . Our long term goal develop new drug target tumor microenvironment novel therapeutic chemoprevention strategy .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Dideoxynucleosides</mesh_term>
	<mesh_term>Alovudine</mesh_term>
	<criteria>Breast biopsy positive invasive malignancy ( core needle , mammatone , incisional biopsy ) Participants must plan surgery Hospital University Pennsylvania Participants must able tolerate lie table hour Newly diagnose primary breast cancer , classify operable ( T1T4 ) Pregnant woman History severe renal disease Prior history breast cancer study breast within last five year .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>